This is the authors' abstract. We don't add key points for this paper.
The results from this study suggest that not only a mutation in the gyrA gene but also reduced drug accumulation in cells contributes to the development of fluoroquinolone a mutation in the gyrA gene contributes to a high level of fluoroquinolone resistance in gonococci with decreases in accumulation in cells having an additional but lesser effect.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tanaka et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: